The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that
it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The
authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks
of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm
published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus
on the new classes of medications that now have more clinical data and experience.
Simultaneous publication: This article is being simultaneously published in 2008 in Diabetes Care and Diabetologia by the
American Diabetes Association and the European Association for the Study of Diabetes. Copyright 2008 by the American Diabetes
Association and Springer. Copying with attribution allowed for any non-commercial use of the work.